Abstract

BackgroundIt is now well established that IL-4 has a central role in the development of monocytes to multinucleated giant cells (MGCs) by inducing the expression of integrins on the surface of monocytes. The aim of this study was to investigate the potential role of IL-4 in induction of β5 integrin expression in the peripheral blood samples of patients with giant cell granuloma.Material and MethodsMonocytes were isolated from peripheral blood samples of patients with central giant cell granuloma (CGCG) and healthy controls using human Monocyte Isolation Kit II. Isolated monocytes were then cultured in the absence or presence of IL-4 (10 and 20 ng/mL), and following RNA extraction and cDNA synthesis, Real-time PCR was performed to determine the level of β5 integrin expression. The formation of CGCGs and morphological analyses were done under light microscopy. For confirmation of CGCGs, immunocytochemistry technique was also carried out by anti-RANK (receptor-activator of NF-κB ligand) antibody.ResultsIn both patient and control groups, β5 levels were significantly enhanced by increasing the IL-4 dose from 10 to 20 ng/mL. In addition, these differences were significant between patient and control groups without IL-4 treatment. On the other hand, the number of cells which expressed RANK and therefore the number of giant cells were significantly higher in the patient group in comparison to controls, as assessed by immunohistochemistry evaluations.ConclusionsIn this study, we showed an elevation in the expression levels of β5 integrin when stimulated by IL-4. It is strongly indicated that this integrin acts as an important mediator during macrophage to macrophage fusion and development of giant cells. Key words:β5 integrin, giant cell, Il-4, monocyte, rank.

Highlights

  • Central giant cell granuloma (CGCG) and peripheral giant cell granuloma (PGCG) are non-neoplastic lesions of jaw bones typically containing many multinucleated giant cells (MGCs) [1]

  • The results showed that an increase in IL-4 dose from 10 to 20 ng/mL causes a statistically significant elevation in expression levels of β5 integrin in patient and control samples (p=0.01 and p=0.02, respectively)

  • The differences between expression levels of β5 integrin, when compared between patient and control group, were significant bghv (p= 0.03 in the absence of IL-4, p

Read more

Summary

Introduction

Central giant cell granuloma (CGCG) and peripheral giant cell granuloma (PGCG) are non-neoplastic lesions of jaw bones typically containing many MGCs [1]. These lesions share common histopathological features and usually occur in the gums as well as alveolar mucosa of mandibular and maxillary bone [2,3]. The aim of this study was to investigate the potential role of IL-4 in induction of β5 integrin expression in the peripheral blood samples of patients with giant cell granuloma. It is strongly indicated that this integrin acts as an important mediator during macrophage to macrophage fusion and development of giant cells

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call